You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an "international dialogue conference" by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the I...
Artificial Intelligence (AI) in healthcare promises to improve the accuracy of diagnosis and screening, support clinical care, and assist in various public health interventions such as disease surveillance, outbreak response, and health system management. But the increasing importance of AI in healthcare means that trustworthy AI is vital to achieve the beneficial impacts on health anticipated by both health professionals and patients. This book presents the proceedings of the 32nd Medical Informatics Europe Conference (MIE2022), organized by the European Federation for Medical Informatics (EFMI) and held from 27 - 30 May 2022 in Nice, France. The theme of the conference was Challenges of Tr...
This book presents a collection of exclusively selected manuscripts on current ethical controversies related to professional practices from an interprofessional perspective. Insights are provided into the diversity of practices and viewpoints from different countries are merged in a unique way. The book contributes to the debate on social and legal issues regarding end-of-life practices such as organ donation, medically assisted dying and advance care planning. In addition, joint international author groups contributed exclusive chapters about European comparisons on end-of-life topics. The focus on country- and culture-specific aspects broadens the view on key issues and makes the book attractive for an international readership. The variety of approaches and methods used informs and inspires the development of new research and best-practice projects.
Providing a thorough, well-researched investigation of the socio-legal issues surrounding medically assisted death for the past century, this book traces the origins of the controversy and discusses the future of policymaking in this arena domestically and abroad. Should terminally ill adults be allowed to kill themselves with their physician's assistance? While a few American states—as well as Holland, Switzerland, Belgium, and Luxembourg—have answered "yes," in the vast majority of the United States, assisted death remains illegal. This book provides a historical and comparative perspective that not only frames contemporary debates about assisted death and deepens readers' understandin...
Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics. Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.
"This is a multi-authored book concerning the perceived threat and recorded increase of emerging pests and vector-borne diseases affecting man and animals in Europe. Historically, Europe suffered from numerous pests and vector-borne diseases, including yellow fever, malaria, plague and typhus. Introduction of hygienic measures, drugs and vector control caused the disappearance of many of these diseases from Europe. In the (sub)tropics, however, many of these diseases still thrive, causing serious health problems for humans and animals. Increased trade, leading to animal and human movement and climate change cause reason to assume that several of these diseases might become re-established or ...
Locating assisted suicide within the broader medical end-of-life context and drawing on the empirical data available from the increasing number of permissive jurisdictions, this book provides a novel examination of the human rights implications of the prohibition on assisted suicide in England and Wales and beyond. Assisted suicide is a contentious topic and one which has been the subject of judicial and academic debate internationally. The central objective of the book is to approach the question of the ban’s compatibility with the European Convention on Human Rights afresh; freed from the constraints of the existing case law and its erroneous approach to the legal issues and selective re...
Unlike Nazi medical experiments, euthanasia during the Third Reich is barely studied or taught. Often, even asking whether euthanasia during the Third Reich is relevant to contemporary debates about physician-assisted suicide (PAS) and euthanasia is dismissed as inflammatory. Physician-Assisted Suicide and Euthanasia: Before, During, and After the Holocaust explores the history of euthanasia before and during the Third Reich in depth and demonstrate how Nazi physicians incorporated mainstream Western philosophy, eugenics, population medicine, prevention, and other medical ideas into their ideology. This book reveals that euthanasia was neither forced upon physicians nor wantonly practiced by...
Over recent years there has been major investment in research infrastructure to harness the potential of routinely collected health data. In 2013, The Farr Institute for Health Informatics Research was established in the UK, undertaking health informatics research to enhance patient and public health by the analysis of data from multiple sources and unleashing the value of vast sources of clinical, biological, population and environmental data for public benefit. The Medical Informatics Europe (MIE) conference is already established as a key event in the calendar of the European Federation of Medical Informatics (EFMI); The Farr Institute has been establishing a conference series. For 2017, ...